NASDAQ: RXSTRxsight Inc Stock Ownership - Who owns Rxsight?
Insider buying vs selling
Have Rxsight Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Scott Gaines | Chief Customer Officer | 2026-02-28 | 2,580 | $7.61 | $19.63kSell |
| Mark Wilterding | Chief Financial Officer | 2026-02-28 | 8,068 | $7.61 | $61.40kSell |
| Ilya Goldshleger | Co-President and Chief Operating Officer | 2025-09-25 | 15,096 | $4.34 | $65.52kBuy |
| Ilya Goldshleger | Co-President and Chief Operating Officer | 2025-09-25 | 8,349 | $4.13 | $34.48kBuy |
| Eric Weinberg | Co-President and Chief Commercial Officer | 2025-06-02 | 188,002 | $3.93 | $738.85kBuy |
| Shelley B. Thunen | Co-President and Chief Financial Officer | 2025-04-14 | 7,792 | $4.34 | $33.81kBuy |
RXST insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RXST insiders and whales buy or sell their stock.
RXST Shareholders
What type of owners hold Rxsight Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ra Capital Management LP | 7.40% | 3,052,796 | $21.43M | Insider |
| Blackrock Inc | 6.55% | 2,705,006 | $18.99M | Institution |
| Vanguard Group Inc | 5.40% | 2,229,539 | $15.65M | Institution |
| Artisan Partners Limited Partnership | 5.23% | 2,157,264 | $15.14M | Institution |
| Millennium Management LLC | 5.16% | 2,129,038 | $14.95M | Institution |
| Rxsight I LLC | 4.89% | 2,016,778 | $14.16M | Insider |
| Nomura Holdings Inc | 4.85% | 2,000,060 | $14.04M | Institution |
| No Street GP LP | 4.79% | 1,975,000 | $13.86M | Institution |
| D E Shaw Co Inc | 4.57% | 1,883,829 | $13.22M | Institution |
| Richard M. Wolfen | 4.46% | 1,840,244 | $12.92M | Insider |
RXST vs Medical Device Stocks
Rxsight Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.